Advil Liqui-Gels 200 mg ibuprofen capsules recalled for improper storage
Family Dollar Stores is recalling Advil Liqui-Gels 200 mg ibuprofen capsules (SKUs 0999841 and 0916071) distributed nationwide due to storage outside labeled temperature requirements.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for a Current Good Manufacturing Practice deviation involving storage temperature violations. Improper storage of pharmaceutical products presents a risk of harm to medication safety and efficacy.
Plain-English summary
Family Dollar Stores, Llc. is recalling Advil Liqui-Gels Solubilized Ibuprofen Capsules, 200 mg in both 20-count and 40-count bottles. The product was distributed nationwide between July 28, 2022 and March 31, 2023. Affected SKU numbers are 0999841 (20-count) and 0916071 (40-count).
The recall was initiated because the product was stored outside its labeled storage temperature requirements, which constitutes a violation of Current Good Manufacturing Practice (CGMP) standards. The U.S. Food and Drug Administration has classified this as a Class II recall.
Consumers should not use any affected product and should contact Family Dollar Stores for replacement or refund information.
The recalled product
- Product
- Advil Liqui-Gels Solubilized Ibuprofen Capsules, 200 mg Pain Reliever/Fever Reducer (NSAID) a) 20-count Liquid Filled Capsule bottles; b) 40-count Liquid Filled Capsule bottles.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug
- Hazard
- improper-storage
- temperature-control
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- SKUs a) 0999841
- b) 0916071 stored and distributed from DCs 07/28/2022 through 03/31/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27